News
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...
Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more ...
Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...
which now has the contradictory impact of raising overall drug prices. Reforms should demand greater transparency in the program and mandate 340B only serves its intended population. These ...
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower ...
Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results